₹ 70.41
3.35 (5.00%)
BSE
V
Rekvina Laboratories
₹ 70.41
BSE
Rekvina Laboratories Fundamentals
Company Valuation
Market Cap (₹ Cr.)
78
PE Ratio
-216.30
PB Ratio
19.31
Dividend Yield
-
ROE
20.74%
ROCE
20.74%
Book Value (₹)
3.47
Face Value (₹)
5.00
Analyse VINRKLB with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 41.30% | 41.30% | 41.30% | 77.00% | 77.00% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 45.99% | 45.88% | 45.86% | 18.96% | 20.03% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VINRKLB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
526075
NSE Scrip Name
VINRKLB
ISIN
INE092O01028

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






